Evidence of neurodegeneration in autism spectrum disorder

Translational Neurodegeneration

Volumn 2, Issue 1, 2013, Pages

  Kern, Janet K ^a,b   Geier, David A ^a   Sykes, Lisa K ^c   Geier, Mark R ^a  

^a Institute of Chronic Illnesses Inc   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c Department of Research   (United States)

Author keywords

Autism; Autism spectrum disorder (ASD); Cytokines; Microglia; Neurodegeneration; Neuronal cell loss; Oxidative stress; Regression

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYGUANINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ASTROCYTE; AUTISM; CELL ACTIVATION; CELL COUNT; CELL LOSS; HUMAN; MENTAL DETERIORATION; MICROGLIA; NERVE CELL; NERVE DEGENERATION; NONVERBAL COMMUNICATION; OXIDATIVE STRESS; PATHOGENESIS; PHYSICAL CAPACITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKILL; SOCIAL BEHAVIOR; VERBAL BEHAVIOR;

EID: 84883601274     PISSN: None     EISSN: 20479158     Source Type: Journal    
DOI: 10.1186/2047-9158-2-17     Document Type: Review

References (70)

1. American Psychiatric Association Diagnostic criteria for autistic disorder. Diagnostic and Statistical Manual of Mental Disorders (Fifth edition) 2013, Washington, DC: American Psychiatric Association, American Psychiatric Association.
2. Geier DA, Kern JK, Geier MR. A prospective cross-sectional cohort assessment of health, physical, and behavioral problems in autism spectrum disorders. Maedica (Buchar) 2012, 7:193-200.
3. Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatr 2005, 6:3-8.
4. Boyle CA, Boulet S, Schieve LA, Cohen RA, Blumberg SJ, Yeargin-Allsopp M, Visser S, Kogan MD. Trends in the prevalence of developmental disabilities in US children, 1997-2008. Pediatrics 2011, 127:1034-1042. 10.1542/peds.2010-2989, 21606152.
5. Centers for Disease Control: Changes in Prevalence of Parent-reported Autism Spectrum Disorder in School-aged U.S. Children: 2007 to 2011-2012 2013, Accessed 07/07/13. http://www.cdc.gov/nchs/data/nhsr/nhsr065.pdf.
6. Stefanatos GA. Regression in autistic spectrum disorders. Neuropsych Rev 2008, 18:305-319.
7. Ozonoff S, Williams BJ, Landa R. Parental report of the early development of children with regressive autism: the delays-plus-regression phenotype. Autism 2005, 9:461-486. 10.1177/1362361305057880, 16287700.
8. Kern JK, Miller VS, Evans PA, Trivedi MH. Efficacy of porcine secretin in children with autism and pervasive developmental disorders. J Autism Dev Disord 2002, 32:153-160. 10.1023/A:1015441428154, 12108616.
9. Goldberg WA, Osann K, Filipek PA, Laulhere T, Jarvis K, Modahl C, Flodman P, Spence MA. Language and other regression: assessment and timing. J Autism Dev Disord 2003, 33:607-616.
10. Malhi P, Singhi P. Regression in children with autism spectrum disorders. Indian J Pediatr 2012, 27:975-981.
11. Ji L, Chauhan V, Flory MJ, Chauhan A. Brain region-specific decrease in the activity and expression of protein kinase a in the frontal cortex of regressive autism. PLoS One 2011, 6:e23751. 10.1371/journal.pone.0023751, 3166116, 21909354.
12. Hansen RL, Ozonoff S, Krakowiak P, Angkustsiri K, Jones C, Deprey LJ, Le DN, Croen LA, Hertz-Picciotto I. Regression in autism: prevalence and associated factors in the CHARGE Study. Pediatrics 2008, 8:25-31. 2447830, 18570650.
13. Werner E, Dawson G. Validation of the phenomenon of autistic regression using home videotapes. Arch Gen Psychiatry 2005, 62:889-895. 10.1001/archpsyc.62.8.889, 16061766.
14. Ozonoff S, Iosif AM, Baguio F, Cook IC, Hill MM, Hutman T, Rogers SJ, Rozga A, Sangha S, Sigman M, Steinfeld MB, Young GS. A prospective study of the emergence of early behavioral signs of autism. J Am Acad Child Adolesc Psychiatry 2010, 49:256-266. e1-2, 2923050, 20410715.
15. Courchesne E, Pierce K, Schumann CM, Redcay E, Buckwalter JA, Kennedy DP, Morgan J. Mapping early brain development in autism. Neuron 2007, 56:399-413. 10.1016/j.neuron.2007.10.016, 17964254.
16. World Health Organization The Global Advisory Committee on Vaccine Safety Statement on Thiomersal. Weekly Epidemiological Record on 7 January 2005 2013, http://www.who.int/vaccine_safety/committee/topics/thiomersal/Dec_2004/en/index.html, World Health Organization.
17. Kemper T, Bauman M. Neuropathology of infantile autism. J Neuropathol Exp Neurol 1998, 57:645-652. 10.1097/00005072-199807000-00001, 9690668.
18. Lee M, Martin-Ruiz C, Graham A, Court J, Jaros E, Perry R, Iversen P, Bauman M, Perry E. Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 2002, 125(Pt 7):1483-1495.
19. Bauman ML, Kemper TL. Neuroanatomic observations of the brain in autism. The neurobiology of autism 1994, Baltimore: Johns Hopkins UP, Bauman ML, Kemper TL.
20. Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, Rutter M, Lantos P. A clinicopathological study of autism. Brain 1998, 121:889-905. 10.1093/brain/121.5.889, 9619192.
21. Palmen SJ, van Engeland H, Hof PR, Schmitz C. Neuropathological findings in autism. Brain 2004, 127(Pt 12):2572-2583.
22. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005, 57:304.
23. Ritvo ER, Freeman BJ, Scheibel AB, Duong T, Robinson H, Guthrie D, Ritvo A. Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC autopsy research reports. Am J Psychiat 1986, 143:862-866.
24. Whitney ER, Kemper TL, Bauman ML, Rosene DL, Blatt GJ. Cerebellar Purkinje cells are reduced in a subpopulation of autistic brains: a stereological experiment using calbindin-D28k. Cerebellum 2008, 7:406-416. 10.1007/s12311-008-0043-y, 18587625.
25. Casanova MF. The neuropathology of autism. Brain Pathol 2007, 417:422-433.
26. Vajda FJ. Neuroprotection and neurodegenerative disease. J Clin Neurosci 2002, 9:4-8. 10.1054/jocn.2001.1027, 11749009.
27. Schuman0n CM, Amaral DG. Stereological analysis of amygdala neuron number in autism. J Neurosci 2006, 26:7674-7679. 10.1523/JNEUROSCI.1285-06.2006, 16855095.
28. van Kooten IA, Palmen SJ, von Cappeln P, Steinbusch HW, Korr H, Heinsen H, Hof PR, van Engeland H, Schmitz C. Neurons in the fusiform gyrus are fewer and smaller in autism. Brain 2008, 131(Pt 4):987-999.
29. Camacho J, Combs Z, Schumman C, Amaral D, Martinez-Cerdeno V. Postmortem analysis of cell density in autistic temporal cortex. Soc Neurosci Annu Meet 2013, http://sfari.org/news-and-opinion/conference-news/2010/society-for-neuroscience-2010/autism-brains-characterized-by-fewer-excitatory-neurons#sthash.OzOcSsEo.dpuf.
30. Carson MJ, Bilousova TV, Puntambekar SS, Melchior B, Doose JM, Ethell IM. A rose by any other name: the potential consequences of microglial heterogeneity during CNS health and disease. Neurotherapeutics 2007, 4:571-579. 10.1016/j.nurt.2007.07.002, 2637868, 17920538.
31. Ginhoux F, Greter M, Leboeuf M, Nand S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845. 10.1126/science.1194637, 3719181, 20966214.
32. Huuskonen J, Suuronen T, Miettinen R, van Groen T, Salminen A. A refined in vitro model to study inflammatory responses in organotypic membrane culture of postnatal rat hippocampal slices. J Neuroinflammation 2005, 2:25. 10.1186/1742-2094-2-25, 1298326, 16285888.
33. Brown GC, Neher JJ. Eaten alive! Cell death by primary phagocytosis: 'phagoptosis'. Trends Biochem Sci 2012, 7:325-332.
34. Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR, Peterson PK. Role of microglia in central nervous system infections. Clin Microbiol Rev 2004, 17:942-964. 10.1128/CMR.17.4.942-964.2004, 523558, 15489356.
35. Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia: intrinsic immuneffector cell of the brain. Brain Res Rev 1995, 20:269-287. 10.1016/0165-0173(94)00015-H, 7550361.
36. Nam MK, Shin HA, Han JH, Park DW, Rhim H. Essential roles of mitochondrial depolarization in neuron loss through microglial activation and attraction toward neurons. Brain Res 2013, 1505:75-85.
37. Perry VH, O'Connor V. The role of microglia in synaptic stripping and synaptic degeneration: a revised perspective. ASN Neuro 2010, 2:e00047. 2954441, 20967131.
38. Morgan JT, Chana G, Pardo CA, Achim C, Semendeferi K, Buckwalter J, Courchesne E, Everall IP. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 2010, 68:368-376. 10.1016/j.biopsych.2010.05.024, 20674603.
39. Pardo CA, Vargas DL, Zimmerman AW. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 2005, 17:485-495. 10.1080/02646830500381930, 16401547.
40. Zimmerman AW, Jyonouchi H, Comi AM, Connors SL, Milstein S, Varsou A, Heyes MP. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neuro 2005, 33:195-201.
41. Enstrom AM, Lit L, Onore CE, Gregg JP, Hansen RL, Pessah IN, Hertz-Picciotto I, Van de Water JA, Pardo CA, Vargas DL, Zimmerman AW. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 2005, 17:485-495. 10.1080/02646830500381930, 16401547.
42. Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Futatsubashi M, Takebayashi K, Yoshihara Y, Omata K, Matsumoto K, Tsuchiya KJ, Iwata Y, Tsujii M, Sugiyama T, Mori N. Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry 2013, 70:49-58. 10.1001/jamapsychiatry.2013.272, 23404112.
43. Tetreault NA, Hakeem AY, Jiang S, Williams BA, Allman E, Wold BJ, Allman JM. Microglia in the cerebral cortex in autism. J Autism Dev Disord 2012, 42:2569-2584. 10.1007/s10803-012-1513-0, 22466688.
44. Xing B, Bachstetter AD, Eldik LJ. Microglial p38α MAPK is critical for LPS-induced neuron degeneration, through a mechanism involving TNFα. Mol Neurodegener 2011, 6:84. 10.1186/1750-1326-6-84, 3292986, 22185458.
45. Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, Ji L, Brown T, Malik M. Elevated immune response in the brain of autistic patients. J Neuroimmunol 2009, 207:111-116. 10.1016/j.jneuroim.2008.12.002, 2770268, 19157572.
46. Chez MG, Dowling T, Patel PB, Khanna P, Kominsky M. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr Neurol 2007, 36:361-365. 10.1016/j.pediatrneurol.2007.01.012, 17560496.
47. Klein JA, Ackerman SL. Oxidative stress, cell cycle, and neurodegeneration. J Clin Invest 2003, 111:785-793. 153779, 12639981.
48. Anderson JK. Oxidative stress in neurodegeneration: cause or consequence?. Nat Neurosci Rev 2004, 5:S18-S25.
49. Gutman J. Glutathione- Your Bodies Most Powerful Protector 2002, Montreal: Communications Kudoca Inc, 3.
50. Esterbrauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991, 11:81-128. 10.1016/0891-5849(91)90192-6, 1937131.
51. Efe H, Deger O, Kirci D, Karahan SC, Orem A, Calapoglu M. Decreased neutrolphil antioxidative enzyme activity and increased lipid peroxidation in hyperlipoproteinemic human subjects. Clin Chem Acta 1999, 279:155-165.
52. Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology 2000, 7:153-163. 10.1016/S0928-4680(00)00053-5, 10996508.
53. Granot E, Kohen R. Oxidative stress in childhood - in health and disease states. Clin Nutr 2004, 23:3-11. 10.1016/S0261-5614(03)00097-9, 14757387.
54. Juurlink BH, Paterson PG. Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. J Spinal Cord Med 1998, 21:309-334.
55. Lopez-Hurtado E, Prieto JJ. A microscopic study of language-related cortex in autism. Am J Biochem Biotechnol 2008, 4:130-145.
56. Evans TA, Siedlak SL, Lu L, Fu X, Wang Z, McGinnis WR, Fakhoury E, Castellani RJ, Hazen SL, Walsh WJ, Lewis AT, Salomon RG, Smith MA, Perry G, Zhu X. The autistic phenotype exhibits a remarkably localized modification of brain protein by products of free radical-induced lipid oxidation. Am J Biochem Biotechnol 2008, 4:61-72.
57. Sajdel-Sulkowska EM, Lipinsk B, Windom H, Audhya T, McGinnis W. Oxidative stress in autism: elevated cerebellar 3-nitrotyrosine levels. Am J Biochem Biotechnol 2008, 4:73-84.
58. Sajdel-Sulkowska EM, Xu M, Koibuchi N. Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism. Cerebellum 2009, 8:366-372. 10.1007/s12311-009-0105-9, 19357934.
59. Sajdel-Sulkowska EM, Xu M, McGinnis W, Koibuchi N. Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD). Cerebellum 2011, 10:43-48. 10.1007/s12311-010-0223-4, 20967576.
60. Chauhan A, Audhya T, Chauhan V. Brain region-specific glutathione redox imbalance in autism. Neurochem Res 2012, 37:1681-1689. 10.1007/s11064-012-0775-4, 22528835.
61. Chauhan A, Gu F, Essa MM, Wegiel J, Kaur K, Brown WT, Chauhan V. Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem 2011, 117:209-220. 10.1111/j.1471-4159.2011.07189.x, 21250997.
62. Wyss-Coray T, Mucke L. Inflammation in neurodegenerative disease-a double-edged sword. Neuron 2002, 35:419-432. 10.1016/S0896-6273(02)00794-8, 12165466.
63. Mizukoshi G, Katsura K, Katayama Y. Urinary 8-hydroxy-2'-deoxyguanosine and serum S100beta in acute cardioembolic stroke patients. Neurol Res 2005, 27:644-646.
64. Roberts AL, Lyall K, Hart JE, Laden F, Just AC, Bobb JF, Koenen KC, Ascherio A, Weisskopf MG. Perinatal Air Pollutant Exposures and Autism Spectrum Disorder in the Children of Nurses' Health Study II Participants. Environ Health Perspec 2013, [Epub ahead of print].
65. Windham GC, Zhang L, Gunier R, Croen LA, Grether JK. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco Bay area. Environ Health Perspect 2006, 114:1438-1444. 10.1289/ehp.9120, 1570060, 16966102.
66. Palmer RF, Blanchard S, Stein Z, Mandell D, Miller C. Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health Place 2006, 12:203-209. 10.1016/j.healthplace.2004.11.005, 16338635.
67. Palmer RF, Blanchard S, Wood R. Proximity to point sources of environmental mercury release as a predictor of autism prevalence. Health Place 2009, 15:18-24. 10.1016/j.healthplace.2008.02.001, 18353703.
68. Geier DA, Audhya T, Kern JK, Geier MR. Differences in blood mercury levels in autism spectrum disorders, is there a threshold level?. Acta Neurobiol Exp 2010, 70:177-186.
69. Desoto MC, Hitlan RT. Blood levels of mercury are related to diagnosis of autism: a reanalysis of an important data set. J Child Neurol 2007, 22:1308-1311. 10.1177/0883073807307111, 18006963.
70. Barcelos GR, Grotto D, de Marco KC, Valentini J, Lengert AV, Oliveira AA, Garcia SC, Braga GU, Schläwicke Engström K, Cólus IM, Broberg K, Barbosa F. Polymorphisms in glutathione-related genes modify mercury concentrations and antioxidant status in subjects environmentally exposed to methylmercury. Sci Total Environ 2013, 463-464C:319-325.